Physician profile
Atul F Kamath
NPI 1891993572
$4,047,516.70
in general payments reported to CMS, 2019-2025
20 companies · $1.3M in 2025
The $1.3M reported for 2025 was more than what 99% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171K · 2020: $234K · 2021: $264K · 2022: $446K · 2023: $559K · 2024: $1.1M · 2025: $1.3M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1.8M · Education: $781K · Travel and Lodging: $182K · Royalty Or License: $91K · Food and Beverage: $19K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,849,781.18 |
| Education | $780,730.70 |
| Travel and Lodging | $181,805.00 |
| Royalty Or License | $90,723.19 |
| Food and Beverage | $19,160.80 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $3,635,601.32 | 2019-2025 | Rosa, G7, Avenir |
| Medical Device Business Services, INC. | $110,374.20 | 2019-2021 | |
| Ortho Development Corporation | $96,964.76 | 2019-2025 | |
| Uoc USA INC | $91,454.15 | 2020-2025 | Resolve, U2 Pf+, U2 Press-Fit |
| Bodycad USA Corp | $58,289.49 | 2019-2023 | Fine Osteotomy, Fine Osteotomy |
| Arthrex, INC. | $21,774.65 | 2019-2022 | |
| Linkbio Corp | $12,150.00 | 2019-2020 | |
| Steris Corporation | $10,300.28 | 2024-2025 | |
| Biocomposites INC | $4,623.20 | 2019-2021 | |
| Intellijoint Surgical INC. | $2,333.50 | 2019-2020 | |
| Stryker Corporation | $1,284.61 | 2019-2025 | Cinchlock, Salvation, Pangea |
| Depuy Synthes Sales INC. | $1,158.27 | 2019-2025 | Actis |
| Maxx Orthopedics, INC. | $520.37 | 2019-2023 | |
| Rock Medical Orthopedics, INC. | $190.28 | 2019 | |
| Orthalign INC | $127.28 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $125.71 | 2019-2022 | |
| Medtronic USA, INC. | $90.99 | 2019 | |
| Medacta USA, INC. | $87.36 | 2020 | |
| Restor3d, INC. | $52.14 | 2025 | |
| Bioventus LLC | $14.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Atul Kamath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.